CRISPR Therapeutics AG (CRSP) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CRSP. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 8,348,977 | $455M | INCREASED |
| State Street | 4,321,666 | $236M | INCREASED |
| Sumitomo Mitsui Trust Group | 1,720,734 | $94M | DECREASED |
| IQ EQ Fund Management (Ireland) | 381,991 | $21M | DECREASED |
| BNY Mellon | 326,761 | $18M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Douglas A Treco (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Christian Rommel (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Briggs Morrison (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Sandesh Mahatme (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Katherine A High (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
Full institutional holdings, insider history, and congressional trades for CRISPR Therapeutics AG on SentiSense.